Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
03 Jul 2024
First 26 Patients recruited in Phase 2A ACCENT Trial
02 Jul 2024
Annual General Meeting to be held Friday 23 August 2024
25 Jun 2024
Notification of cessation of securities - ATX
20 Jun 2024
Change of Director's Interest Notice - Dr Robert Peach
11 Jun 2024
Presentation and Webinar
03 Jun 2024
Amplia Establishes World Class Clinical Advisory Board
30 May 2024
Appendix 4G - Key to Corporate Governance Disclosures
30 May 2024
2024 Corporate Governance Statement
30 May 2024
Preliminary Final Report and Annual Report YE 31 March 2024
24 May 2024
ASCO Conference Abstract
Previous
1
2
3
4
5
6
7
8
Next